Company intelligence / Profile preview
SlimFuse
- Ownership
- Private
- Development stage
- Other
Overview
SlimFuse is a biotechnology company dedicated to developing next-generation therapies for obesity and metabolic diseases. Incubated by Versant Ventures, the company utilizes its proprietary "Fuse" platform to engineer long-acting peptide therapeutics, including multi-agonists targeting GLP-1, GIP, and glucagon receptors. By optimizing the pharmacokinetic profiles of these metabolic hormones, SlimFuse aims to provide more effective and convenient treatment options for patients struggling with weight management and related metabolic conditions. The company is part of a growing wave of startups seeking to innovate beyond current GLP-1 therapies by improving durability and efficacy.
- Therapeutic areas
- EndocrinologyMetabolic Disorders
- Modalities
- PeptidesRecombinant fusion protein
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on SlimFuse.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SlimFuse.